Glicklich Alan 4
4 · CHINOOK THERAPEUTICS, INC. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Glicklich Alan
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-10+50,000→ 50,000 totalExercise: $15.14Exp: 2031-02-09→ Common Stock (50,000 underlying) - Award
Restricted Stock (RSU)(Common Stock)
2021-02-10+17,005→ 17,005 totalExp: 2024-02-10→ Common Stock (17,005 underlying)
Footnotes (3)
- [F1]The stock option vests as to 25% of the total shares on February 10, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date.